Hypertension is poorly managed. Hospital-based pharmacists working with physicians have been shown to improve the rate of achievement of 'target' blood pressure in selected patients. It is unknown if such schemes can operate in the community and to what extent they would attract volunteers with poorly managed blood pressure. We assessed the feasibility of pharmacists to provide community-based, open-access, blood pressure monitoring. In addition, we describe the blood pressure profile of the group in comparison to that of the 1994 Health Survey of England (HSE). Pharmacists from six pharmacies were trained to deliver the service. Adults living within the postal districts of the pharmacies were invited, through an advertising campaign, to volunteer to have their blood pressure measured. Blood pressure data and information on treatment for hypertension and/or diabetes were collected on 263 registrants. Patients were advised to have their blood
Introduction
Hypertension is a major, modifiable risk factor for stroke and coronary artery disease. A considerable body of evidence has demonstrated the beneficial effect on the incidence of these outcomes by lowering blood pressure with pharmacological agents. 1, 2 However, these circulatory diseases remain the major cause of death in the United Kingdom. The 1994 Health Survey of England (HSE) suggested that only 50% of subjects with hypertension (blood pressure у160/95 mm Hg) were receiving treatment and of these only 30% had controlled blood pressure (Ͻ160/95 mm Hg). 3 The reasons for the limited success in the detec- tion and management of hypertension are complex. Factors include failures of health care delivery systems and poor patient compliance with treatment regimens. An indirect relationship has been reported between the frequency of blood pressure measurement and the incidence of stroke. 4 However, achievement of 'target' blood pressure is not simply related to the frequency of visits to the physician. 5 Therefore, facilitating blood pressure measurement must be linked to strategies to improve detection and compliance with efficacious treatment regimens. Furthermore, a population-based approach to blood pressure reduction could yield significant benefits in communities at high risk of hypertensiverelated disease.
Hypertension clinics which are hospital-based, or shared between primary and secondary care physicians achieve similar levels of blood pressure control as those run by primary care physicians alone. A number of studies from the United States have examined the effect of hospital-based, physician vs Journal of Human Hypertension pharmacists care of hypertensive patients. These short-term studies have shown that pharmacist involvement is associated with improved patient satisfaction, compliance with therapy and greater success in achieving 'target' blood pressure. 6, 7 It is unclear if this approach can be used in communities. Here, we give details of a novel approach to open-access blood pressure measurement in an inner-city community provided by pharmacists working in partnership with primary care physicians. In addition, we compare the prevalence and control of hypertension in relation to that of the HSE.
Patients and methods
The Whittington Hospital provides health care for the residents of North Islington which is an innercity area of North London, England, served by the Camden and Islington (C&I) Health Authority. The catchment area has an estimated, 153 400 adults aged у25 years of Caucasian (77%), black (10%) and Indo-Asian (9%) origin.
The project was co-ordinated from the Whittington Hospital and ran for 16 weeks from October 1999. All the pharmacies registered with C&I Health Authority expressed an interest to take part in the project. The 151 general practices in the health authority's catchment area were informed about the pilot study and agreed to review any patient who was referred as a result of the screening. We selected six pharmacies located in the hospital's catchment area that had suitable facilities for adult clients to have their blood pressure measured in the seated position.
Pharmacist training protocol
The training programme consisted of two 3-h sessions on separate days. In the first session, a physician explained the physiology of blood pressure, its measurement and recording, association with cardiovascular disease and the benefits of non-pharmacological treatment. In the second session, a team of research nurses demonstrated blood pressure measurement according to the British Hypertension Society (BHS) guidelines 8 using the Omron HEM-705 CP automated oscillometric digital blood pressure monitor (Omron, Tokyo, Japan). Each pharmacist had to demonstrate that they could successfully: (a) operate the device, (b) select the appropriate cuff according to arm circumference, (c) provide a written record of blood pressure, (d) understand the registration procedure, and (e) be able to give further advice for repeat blood pressure measurement.
Patient recruitment, registration and blood pressure measurement
People living within the catchment area were invited to take part in the project in three ways. Firstly, each pharmacy promoted the service in their premises by advertising specifically designed posters in the main window and hand-out material on their main counters inviting clients to have their blood pressure measured. Secondly, pamphlets containing details of the project and the participating pharmacies were distributed in libraries, retail outlets, job and community centres. Finally, details were published in a free newspaper that was delivered to each household in the catchment area in the week the project was launched. Any adult was eligible to enrol in the scheme. All consenting volunteers were asked to register using a standardised form provided on-site by the pharmacists. The forms were completed in private. Information was collected on racial origin (IndoAsian, African-Caribbean, Caucasian or other), treatment for diabetes and/or hypertension, general practitioner details and the time interval of their last (previous) blood pressure measurement. Completed forms were collected by the pharmacist who provided volunteers with a record card with their unique identification number.
Blood pressure was measured twice in the sitting position with at least 5 min rest between the first and second readings. Patients were provided with a written record of the measurement. Pharmacists used an algorithm based on BHS guidelines, 8 to provide immediate feedback on the significance of the reading and the schedule for repeat measurement ( Table 1 ). The registration data and blood pressure reading from the monitor was returned to the coordinating centre in the Whittington Hospital by post.
Data management
The data were processed by an in-house decisionsupport and management software programme. This was used to confirm the advice of the pharmacists and provide personalised prompts for patients to seek further management. The system was implemented in Prolog software. A graphical user interface provided two data entry screens, one for the capture of demographic data about the patient and one to record the blood pressure measurements. The system was based on the BHS guidelines. 9 These used the recorded blood pressure measurements and the additional clinical and demographic information provided, to identify the appropriate advice. In each case the advice consisted of a management plan, a suggested interval for a follow-up and a short explanation of the advice. Text strings containing each of the elements of the selected advice were then incorporated into standard letters to be sent to the patient and, where appropriate (category 1), the patient's general practitioner (Figure 1) . We contacted the general practices of patients in category 1 by telephone to assess whether the patient had made an appointment for further assessment.
Hypertension was defined as a systolic blood pressure у160 mm Hg, a diastolic pressure у95 mm Hg or a subject receiving antihypertensive therapy. Control of hypertension was defined as a subject's receiving antihypertensive therapy and having a systolic blood pressure Ͻ160 mm Hg and a diastolic blood pressure Ͻ95 mm Hg. These cut-offs were chosen to allow comparison of our data with HSE data.
Statistics
Data were analysed with SPSS 8.0 for Windows (Chicago, USA) using parametric or non-parametric Figure 1 Relationship between visits to pharmacies and primary care physicians (patient track →) for blood pressure measurement and the collation and assessment of data (data track --→). Decision support analyses: category 1, immediate referral; category 2, re-assessment in 2-3 months (includes patients with diabetes and hypertension); category 3 routine follow-up in 12 months.
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tests according to the distribution of the variable. Analysis of variance was used for comparisons between more than two groups. Categorical variables were analysed with Chi-squared. Data are reported as mean (standard deviation s.d.) unless otherwise stated. A P value Ͻ0.05 was considered statistically significant.
Results
Over a 16-week period 263 subjects enrolled in the study. The 115 males and 148 females were of similar age (54.6(13.1) and 53.8(17.2) years respectively; P ϭ 0.67). Indo-Asian and African-Caribbean subjects respectively comprised 12 and 14% of the cohort. However, the proportion of men was significantly greater amongst the Indo-Asian group compared to the Caucasians and African-Caribbean groups (P ϭ 0.037). There was no difference in the proportion of patients receiving antihypertensive treatment (n ϭ 91) according to race (African-Caribbean vs Indo-Asian vs Caucasian, 44 vs 31 vs 32% respectively; P ϭ 0.87). Treatment for diabetes was higher amongst men (10.5%) than women (3.4%) (P ϭ 0.02) and was two to four-fold greater amongst Asian (13.8%) and African-Caribbean (8.8%) subjects compared with Caucasians (3.8%) (P ϭ 0.07).
Evaluation of blood pressure
The time between blood pressure measurements as recorded by the blood pressure monitor (lag-time) was 5.3 (1.9) min. There was no correlation between lag-time and either systolic (SBP) or diastolic (DBP) blood pressure. The prevalence of hypertension among the patients who attended the pharmacies for blood pressure measurement according to gender and treatment for hypertension in comparison to the HSE-dataset is shown in Table 2 . Patients were appropriately categorised according to their blood pressure. Those in category 1 (n ϭ 16) had significantly higher SBP and DBP than those in categories 2 (n ϭ 117) and 3 (n ϭ 130) (186(16)/97(29) vs 151(13)/94(9) vs 139(22)/86(13) mm Hg; respectively, ANOVA, SBP: F ϭ 291.6; P Ͻ 0.001, DBP: F ϭ 68.5 P Ͻ 0.001). Category 1 patients were also older than those in categories 2 and 3 (65.3(13.9) vs 56.7(15.5) vs 48.7(16.5) years; P Ͻ 0.001). All patients in category 1 attended their surgery as recommended for further evaluation.
Known hypertensive subjects were more than twice as likely to have had their blood pressure measured within the previous 6 months by their general practitioner compared with subjects without a previous history of hypertension ( 2 ϭ 59.38; P Ͻ 0.001) ( Table 3) .
Discussion
This study demonstrates that pharmacists can take a leading role in blood pressure surveillance. Importantly, the scheme captured data from a representative sample of an inner-city community. The main ethnic groups of African-Caribbean and IndoAsian compose 10.6% and 6.2% of the North Islington population. 10 The proportion of registrants in the scheme from these groups was higher than expected. This is an interesting (and encouraging) observation as it suggests that people from these minor ethnic groups who have an increased prevalence of hypertension and diabetes mellitus, and consequently a higher burden of hypertensiverelated diseases than Caucasians, are not less likely to use the scheme.
We found the prevalence of hypertension (blood pressure of у160/95 mm Hg) among people who attended the pharmacy for blood pressure measurement to be more than two-fold greater than that found in the 1994 Health Survey of England. If we had used the more stringent cut-off of у140/90 mm Hg the prevalence of hypertension would have been 53%. These figures are likely to be an overestimate because blood pressure was measured on one occasion. However, our results are similar to that of a survey in adults using single, electronic measurements of blood pressure. 11 Data collected in this manner in the assessment of overall cardiovascular risk has important prognostic value. 12 Our data and that of the HSE show that patients with hypertension remain poorly managed. Of interest, the prevalence of hypertension was higher in our cohort. There were no gender differences between the cohorts but a smaller proportion of patients were receiving antihypertensive treatment in our group. There was no evidence that there were methodological differences in the way blood pressure was measured between those with and without hypertension in our patients. Lag-times (used as a measure of protocol compliance) were similar in both groups and there was no difference between pharmacies (data not shown). We cannot exclude a form of 'white coat' hypertension in the pharmacy setting to account for the differences in prevalence of hypertension in the two data sets.
Previous studies have highlighted the importance of the role of pharmacists as educators. Pharmacists have been shown to favourably influence blood pressure control by emphasising the benefits of nonpharmacological therapy. However, a potential area of conflict in the physician-pharmacist collaboration concerns recommendation for further management. A computerised decision-support and management system has the ability to provide standardised information to health carers and individualised feedback for the patients. In our pilot study we provided each patient with written advice based on the measurements by the pharmacist. The main effect of the decision-support was to reinforce the need for patients being treated for hypertension and diabetes mellitus to have blood pressure measured more frequently if they had a blood pressure that was Ͻ140/90 mm Hg. This is an important administrative element of the project which involves the patient in their own care. Frequency of blood pressure measurement is only one aspect of achieving good control. We found that patients who had had their blood pressure measured within 6 months were most likely to be hypertensive and have the highest blood pressures. A recent review of 17 randomised controlled trials using health care decision aids concluded that they improved knowledge, decreased decisional conflict and increased participation in decision making in screening and treatment decisions. 13 Shared-management for hypertensive patients between primary and secondary care may be costeffective but it is not a model that can be easily generalised.
14 In a population at high risk of hypertensive-related diseases, our model would potentially make better use of physician time by targeting and referring only those patients with a high probability of undiagnosed or poorly managed hypertension for further management according to agreed protocols. Patients in need of intensive-care could receive this at their convenience. We found that 38% of patients with blood pressure у160/95 mm Hg were not on antihypertensive therapy. Therefore, a physicianpharmacist partnership is feasible for the surveil-lance and management of hypertension. A long-term study is now required to assess whether patient satisfaction with the decisions made are related to a reduction in the incidence of hypertensive-related disease.
